03.03.2025
Egnach, March 3, 2025 – Resaphene Suisse AG announces that the company has successfully completed certification for the Indian market. The certification enables the company to launch and distribute its medical devices in India.
This is a significant milestone for Resaphene, facilitating our market entry in India and providing our customers with the assurance that our products meet the required standards.
++ About Resaphene Suisse AG
Resaphene Suisse AG, based in Egnach, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.
++ Contact for questions:
Resaphene Suisse AG
Mrs. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland
T. +41 71 510 07 24
a.rauterkus@resaphene.ch